<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">J. Clin. Microbiol</journal-id><journal-id journal-id-type="hwp">jcm</journal-id><journal-id journal-id-type="pmc">jcm</journal-id><journal-id journal-id-type="publisher-id">JCM</journal-id><journal-title-group><journal-title>Journal of Clinical Microbiology</journal-title></journal-title-group><issn pub-type="ppub">0095-1137</issn><issn pub-type="epub">1098-660X</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7180238</article-id><article-id pub-id-type="pmid">32161092</article-id><article-id pub-id-type="publisher-id">00187-20</article-id><article-id pub-id-type="doi">10.1128/JCM.00187-20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject></subj-group></article-categories><title-group><article-title>Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options</article-title><alt-title alt-title-type="running-head">Minireview</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4954-0748</contrib-id><name><surname>Khan</surname><given-names>Suliman</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Siddique</surname><given-names>Rabeea</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shereen</surname><given-names>Muhammad Adnan</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ali</surname><given-names>Ashaq</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jianbo</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bai</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bashir</surname><given-names>Nadia</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xue</surname><given-names>Mengzhou</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><label>a</label><addr-line>Department of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China</addr-line></aff><aff id="aff2"><label>b</label><addr-line>Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China</addr-line></aff><aff id="aff3"><label>c</label><addr-line>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China</addr-line></aff><aff id="aff4"><label>d</label><addr-line>Wuhan institute of Virology, Chinese Academy of Sciences, Wuhan, China</addr-line></aff><aff id="aff5"><label>e</label><addr-line>Department of Respiratory Medicine, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China</addr-line></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kraft</surname><given-names>Colleen Suzanne</given-names></name><role>Editor</role><aff>Emory University</aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Suliman Khan, <email>Suliman.khan18@mails.ucas.ac.cn</email>, or Mengzhou Xue, <email>xuemengzhou@zzu.edu.cn</email>.</corresp><fn fn-type="other"><p><bold>Citation</bold> Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M. 2020. Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options. J Clin Microbiol 58:e00187-20. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.00187-20">https://doi.org/10.1128/JCM.00187-20</ext-link>.</p></fn></author-notes><pub-date pub-type="epreprint"><day>11</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>4</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>58</volume><issue>5</issue><elocation-id>e00187-20</elocation-id><permissions><copyright-statement>Copyright &#x000a9; 2020 American Society for Microbiology.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Society for Microbiology</copyright-holder><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="JCM.00187-20.pdf"/><abstract abstract-type="precis"><p>The new decade of the 21<sup>st</sup> century (2020) started with the emergence of a novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans, and mechanisms associated with the pathogenicity of SARS-CoV-2 are not yet clear, however, its resemblance to SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing-related studies.</p></abstract><abstract><title>ABSTRACT</title><p>The new decade of the 21<sup>st</sup> century (2020) started with the emergence of a novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans, and mechanisms associated with the pathogenicity of SARS-CoV-2 are not yet clear, however, its resemblance to SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing-related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infections. In this review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>novel coronavirus</kwd><kwd>outbreak</kwd><kwd>therapeutics</kwd><kwd>transmission</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>Postdoctoral grant from The Second Affiliated Hospital of Zhengzhou University</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>khan</surname><given-names>Suliman</given-names></name></principal-award-recipient></award-group><award-group id="award2"><funding-source><institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id>https://doi.org/10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>81471174</award-id><award-id>81520108011</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Mengzhou</given-names></name></principal-award-recipient></award-group></funding-group><counts><fig-count count="0"/><table-count count="1"/><equation-count count="0"/><ref-count count="65"/><page-count count="9"/><word-count count="7227"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2020</meta-value></custom-meta><custom-meta><meta-name>access-type</meta-name><meta-value>free</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Coronaviruses are enveloped, positive-sense single-stranded RNA viruses with a nucleocapsid of helical symmetry (<xref rid="B1" ref-type="bibr">1</xref>). Coronaviruses have been widely identified as causing respiratory and intestinal infections in humans after the outbreak of severe acute respiratory syndrome (SARS) in Guangdong, China in 2002 and 2003 (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). SARS was determined to be caused by SARS-CoV and emerged in a market where civets were sold (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Only a decade later, the world witnessed another outbreak in the form of Middle East respiratory syndrome (MERS) caused by MERS-CoV in the Middle East (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). While the researchers were still investigating the underlying mechanisms of pathogenicity and developing effective therapeutic strategies against MERS, the world witnessed the deadliest outbreak in the form of COVID-19 (<xref rid="B6" ref-type="bibr">6</xref>). The causative coronavirus of this outbreak was named SARS-CoV-2 due to its resemblance to SARS-CoV (<xref rid="B7" ref-type="bibr">7</xref><xref ref-type="bibr" rid="B8">&#x02013;</xref><xref rid="B9" ref-type="bibr">9</xref>). The SARS-CoV infects ciliated bronchial epithelial cells and type-II pneumocytes through angiotensin-converting enzyme 2 (ACE2) as a receptor (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B10" ref-type="bibr">10</xref>). MERS infects unciliated bronchial epithelial cells and type-II pneumocytes by using dipeptidyl peptidase 4 (DPP4), also known as CD26, as a receptor (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The mechanisms associated with the infectiousness of SARS-CoV-2 are not clear, however, structural analysis suggests it is likely entering human cells through the ACE2 receptor (<xref rid="B12" ref-type="bibr">12</xref>). This newly emerged virus has much greater similarity to SARS-CoV than to MERS-CoV, thus both SARS-CoV and SARS-CoV-2 may cause pathogenesis through similar mechanisms. The transmission of SARS-CoV to humans was reported from market civets, while that of MERS-CoV was from dromedary camels (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). Similarly, the newly emerged SARS-CoV-2 also appears to be transmitted to humans from markets where wild animals are sold (<xref rid="B8" ref-type="bibr">8</xref>). However, the zoonotic source of its transmission is not yet clear. According to previous reports, the aforementioned three coronaviruses are thought to have originated in bats (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>).</p><p>Since the first epidemic of SARS, the pathogenic coronaviruses have harmed thousands of people worldwide (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Considering the adverse outcomes of the current COVID-19 epidemic, developing effective therapeutic strategies is necessary to cope with the lack of effective drugs, high mortality rate, and the potential of the virus to cause further epidemics. In this review, we focus on the origin, evolution, and pathogenicity of SARS-CoV, MERS-CoV, and SARS-CoV-2. We also discuss the therapeutic options for SARS-CoV-2 given its importance in the current scenario of COVID-19 outbreak in Wuhan, China. This review will be useful in preparing against future outbreaks and continuing pathogenic infections by this class of novel coronaviruses virulent to humans.</p></sec><sec id="s2"><title>DIVERSITY AND ORIGIN OF HIGHLY PATHOGENIC CORONAVIRUSES</title><p>Coronaviruses are members of the subfamily <italic>Coronavirinae</italic> (family <italic>Coronaviridae</italic>; order <italic>Nidovirales</italic>), which contains four genera: <italic>Alphacoronavirus</italic>, <italic>Betacoronavirus</italic>, <italic>Gammacoronavirus</italic>, and <italic>Deltacoronavirus</italic> (<xref rid="B2" ref-type="bibr">2</xref>). Gamma- and deltacoronaviruses generally infect birds, although some of them can cause infection in mammals, whereas, alpha- and betacoronaviruses are known to harm humans and animals. The viruses SARS-CoV (betacoronavirus), 229E (alphacoronavirus), HKU1 (betacoronavirus), NL63 (alphacoronavirus), OC43 (betacoronavirus), and MERS-CoV (betacoronavirus) can all cause infections in humans (<xref rid="B2" ref-type="bibr">2</xref>). However, betacoronaviruses are the most important group because they comprise the most highly pathogenic viruses against humans, including SARS-CoV-2, MERS-CoV, and SARS-CoV (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). The highly pathogenic MERS and SARS coronaviruses originated in bats (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>), however, the origin of the newly emerged SARS-CoV-2 remains debatable. Investigations have revealed that the SARS-CoV strains detected in market civets (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>) were transmitted from horseshoe bats (<xref rid="B22" ref-type="bibr">22</xref>). These viruses were found to be phylogenetically related to SARS-CoV in bats from China, Europe, Southeast Asia, and Africa (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). In addition, the genome sequences of SARS-CoV strains isolated from humans were highly similar to those in bats (<xref rid="B21" ref-type="bibr">21</xref>). However, some variations were found among the <italic>S</italic> gene and <italic>ORF3</italic> and <italic>ORF8</italic> gene sequences, which encode a binding and fusion protein and dispensable proteins for replication, respectively (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Nevertheless, clade2 of the <italic>S</italic> genetic region (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B24" ref-type="bibr">24</xref>), <italic>ORF8</italic> (<xref rid="B23" ref-type="bibr">23</xref>), and <italic>ORF3b</italic> in SARS-CoV from bats contain major variations compared to SARS-CoV from humans (<xref rid="B23" ref-type="bibr">23</xref>).</p><p>Different strains of MERS-CoV obtained from camels were found to be similar to those isolated from humans (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>) except for variations among the <italic>S</italic>, <italic>ORF4b</italic>, and <italic>ORF3</italic> genomic regions (<xref rid="B26" ref-type="bibr">26</xref>). Furthermore, genome sequencing-based studies have revealed that MERS-CoV strains from humans are phylogenetically related to those from bats. The strains have identical genomic and protein structures except for the S proteins (<xref rid="B27" ref-type="bibr">27</xref>). In addition, recombination analysis of genes encoding orf1ab and S revealed that MERS-CoV originated from the exchange of genetic elements between coronaviruses in camels and bats (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B28" ref-type="bibr">28</xref>).</p><p>Although the zoonotic source of SARS-CoV-2 is not confirmed, its genome sequence exhibits close relatedness (88% identity) with two bat-derived SARS-like coronaviruses (bat-SL-CoVZC45 and bat-SL-CoVZXC21). Phylogenetic analysis reveals that SARS-CoV-2 is genetically distinct from SARS-CoV and MERS-CoV. However, homology modeling reveals that both SARS-CoV and SARS-CoV-2 have similar receptor-binding domain structures, despite amino acid variation at some key residues, including the absence of the 8a protein and the fluctuation in the number of amino acids in the 8b and 3c proteins in SARS-CoV2 (<xref rid="B29" ref-type="bibr">29</xref>). In contrast, the primary protease is highly conserved between SARS-CoV-2 and SARS-CoV, with a 96% overall identity (<xref rid="B30" ref-type="bibr">30</xref>). These observations suggest that bats are the source of origin, while an animal sold at the Wuhan seafood market might represent an intermediate host facilitating the emergence of the virus in humans (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B31" ref-type="bibr">31</xref>).</p></sec><sec id="s3"><title>EPIDEMIOLOGY AND CLINICAL FEATURES OF HUMAN CORONAVIRUSES</title><p>After the emergence of SARS-CoV in the Guangdong province of China, it rapidly spread around the globe (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). During November 2002, an epidemic of pneumonia with a high rate of transmission to other people occurred in Guangdong, China (<xref rid="B32" ref-type="bibr">32</xref>), followed by subsequent outbreaks in Hong Kong. In Hong Kong, a total of 138 people contracted the infection within 2 weeks after the exposure to an infected patient in the general ward of a hospital (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B32" ref-type="bibr">32</xref>). Overall, SARS-CoV infected 8,098 people and caused 774 fatalities in 29 different countries by the end of the epidemic (<xref rid="B1" ref-type="bibr">1</xref>). Later, during June 2012, a patient infected by MERS-CoV developed severe pneumonia and died in Jeddah, Saudi Arabia (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Analysis of cluster of nosocomial cases in Jordan during April 2012 confirmed that MERS-CoV caused the outbreak (<xref rid="B34" ref-type="bibr">34</xref>). The spread of MERS-CoV continued beyond the Middle East, causing further reports of infected individuals (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Until 2020, 2,468 cases and 851 fatalities had been reported globally (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). During December 2019, clusters of patients with atypical pneumonia were reported by local health facilities in Wuhan, China. On December 31, 2019, a rapid response team was dispatched by the Chinese Center for Disease Control and Prevention (China CDC) to conduct an epidemiologic and etiologic investigation (<xref rid="B37" ref-type="bibr">37</xref>). The patients were found epidemiologically linked to the wet animal wholesale seafood market in Wuhan, China. Later, the infectious agent responsible for this atypical pneumonia was confirmed and reported as coronavirus SARS-CoV-2, which caused the first fatality in early January 2020 (<xref rid="B15" ref-type="bibr">15</xref>). During the first 6 weeks of the outbreak, several cases were reported in more than 37 countries, including the USA, Japan, Iran, and South Korea (<xref rid="B38" ref-type="bibr">38</xref>). The infection rapidly spread across the globe from Wuhan, China. Therefore, the Chinese authorities implemented several strategies, including massive lockdown in Wuhan and suspension of transport to and from Wuhan to control the spread (<xref rid="B17" ref-type="bibr">17</xref>). According to Situation Report 35, published on the WHO website, SARS-CoV-2 caused 79,331 confirmed cases and 2,618 deaths around the globe. However, COVID-19 caused 77,262 confirmed cases and 2,595 deaths inside mainland China alone (<xref rid="B38" ref-type="bibr">38</xref>). Through February 24, WHO had reported 8 deaths in Iran. It is now the second country after China, bearing the highest fatalities due to SARS-CoV-2 infection. (<xref rid="B38" ref-type="bibr">38</xref>). The spread of SARS-CoV-2 in Iran poses a higher risk of pandemics in the Middle East and South Asian countries. Between December 10 and January 4, analysis of the growth rate of the epidemic gave a basic reproductive number (R<sub>0</sub>) of 2.2, meaning each patient has been spreading the infection to 2.2 other individuals (<xref rid="B39" ref-type="bibr">39</xref>). The estimated R<sub>0</sub> value for SARS was around 3, however, SARS was successfully controlled by isolation of patients (<xref rid="B39" ref-type="bibr">39</xref>). Moreover, the R<sub>0</sub> for MERS ranged from 0.45 in Saudi Arabia to 8.1 in South Korea (<xref rid="B36" ref-type="bibr">36</xref>). Considering the lower R<sub>0</sub> value, the rapid increase in suspected as well confirmed cases of COVID-19 may be inferred via viral transmission through the fecal-oral route and aerosol formation. Moreover, asymptomatic persons are thought to be potential sources of SARS-CoV-2 infection (<xref rid="B40" ref-type="bibr">40</xref>), which may have caused the rapid spread of SARS-CoV-2. This asymptomatic spread may be one reason that the control strategy based on the isolation of patients has not been fully successful. To overcome these problems, a complete quarantine is necessary, allowing all of the infected individuals to develop symptoms without spreading the virus randomly. Thus, the direct and indirect contacts of infected individuals can be easily identified and isolated.</p><p>Clinical features associated with patients infected with SARS-CoV, MERS-CoV, and SARS-CoV-2 range from mild respiratory illness to severe acute respiratory disease (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Both MERS and SARS patients in later stages develop respiratory distress and renal failure (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Pneumonia appears to be the most frequent manifestation of SARS-CoV-2 infection, characterized primarily by fever, cough, dyspnea, and bilateral infiltrates on chest imaging (<xref rid="B17" ref-type="bibr">17</xref>). The period from infection to appearance of symptoms varies. Generally, it is thought to be 14&#x02009;days, however, a research group at Guangzhou Medical University reported the incubation period to be 24&#x02009;days. In a family cluster of infections, the onset of fever and respiratory symptoms occurred approximately 3 to 6 days after presumptive exposure (<xref rid="B41" ref-type="bibr">41</xref>).</p></sec><sec id="s4"><title>DIAGNOSTIC TESTING</title><p>Diagnostic testing for the SARS-CoV-2 is primarily done in public health laboratories. Delays in testing result from the need for administrative oversight of testing at the national or regional level, as well as the time needed to transport specimens and the high volume of testing needed in some regions. More rapid testing should be widely available in the event of epidemics. High-level testing facilities at regional hospitals and commercial laboratories are needed, in addition to the commercially available tests that have undergone regulatory approval. Several tests have been validated by public health authorities, including those in China, Germany, Thailand, Japan, and the United States (WHO, COVID-19, technical guidance, Feb 12, 2020). These tests are reverse transcriptase PCR (RT-PCR) tests that use primers and probes designed to detect a variety of targets in the SARS-CoV-2 genome. Although these have been designed and validated, there is currently very limited information available related to the performance of these tests. The sensitivity and specificity of the tests are not widely known, and some of them might detect other related coronaviruses, such as SARS-CoV. In addition, the utility of different specimen types for detection of the viruses is not known. As a result, testing of multiple specimen types is recommended by some agencies, including the CDC (<xref rid="B42" ref-type="bibr">42</xref>). The availability of serological tests is unclear and, presumably, such tests are in development. Moreover, the collection and submission of sera from potentially infected patients is recommended by some public health laboratories.</p><p>The CDC and WHO have both issued recommendations for laboratory safety when testing specimens from patients suspected of being infected with SARS-CoV-2 (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Both guidelines recommend that manipulation of potentially infectious specimens should be done in a biosafety cabinet if there is potential for splashes or generation of droplets or aerosols. Viral isolation (culture) should be done only in BL-3 laboratories. Testing in chemistry and hematology laboratories can be done following routine laboratory precautions recommended for such work.</p></sec><sec id="s5"><title>THERAPEUTIC OPTIONS FOR HUMAN CORONAVIRUSES</title><p>Currently there are no promising antiviral treatments available, however, numerous compounds have been proven effective against SARS-CoV and MERS-CoV but have not been tested widely for the newly emerged SARS-CoV-2. Remdesivir and chloroquine were found highly effective <italic>in vitro</italic> for the control of 2019-nCoV infection (<xref rid="B44" ref-type="bibr">44</xref>). Treatment with remdesivir alone or in combination with chloroquine or interferon beta was found effective against COVID-19 infection. This strategy has not caused any obvious side effects yet (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). However, more investigations are necessary to confirm the impacts of remdesivir. As coronaviruses share key genomic elements, common therapeutic targets are likely to be of greater importance. Therapeutic agents targeting nucleosides, nucleotides, viral nucleic acids, and enzymes/proteins involved in the replication and transcription of coronaviruses can be promising strategies to treat coronavirus diseases (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B1" ref-type="bibr">1</xref>). The surface spike glycoprotein (S) is an important potential target for antiviral agents, due to its vital role in the interaction between the virus and the cell receptor. S consists of two subunits: S1, the amino-terminal receptor binding subunit, and S2, the carboxy-terminal membrane fusion subunit (<xref rid="B46" ref-type="bibr">46</xref>). In addition, activation of membrane fusion and virus entry requires the cleavage at the junction of S1-S2 (<xref rid="B46" ref-type="bibr">46</xref>). Hence, S1 subunit-targeting monoclonal antibodies and S2 subunit-targeting fusion inhibitors may be effective therapeutic agents for coronaviruses (<xref rid="B1" ref-type="bibr">1</xref>). Furin (a serine endoprotease) cleaves off S1/S2 (<xref rid="B47" ref-type="bibr">47</xref>) could thus be a suitable antiviral agent. Further, the helical nucleocapsid interacts with S protein, envelope proteins, and membrane proteins to form the assembled virion (<xref rid="B1" ref-type="bibr">1</xref>). Therefore, targeting the structural genes using small interfering RNAs could be an effective therapeutic strategy against coronaviruses (<xref rid="B1" ref-type="bibr">1</xref>). The host receptors are also associated with the viral entry into host cells, thus agents targeting these receptors also inhibit coronaviruses (<xref rid="B46" ref-type="bibr">46</xref>). Inhibitors of endosomal cysteine protease and transmembrane protease serine 2 can partially block viral entry into the cell (<xref rid="B48" ref-type="bibr">48</xref>). K22 targets membrane-bound RNA synthesis in coronaviruses and inhibits double-membrane vesicle formation (<xref rid="B49" ref-type="bibr">49</xref>), and thus could be effective against SARS-CoV-2.</p><table-wrap id="T1" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Therapeutic options for COVID-19</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Therapeutic name</th><th rowspan="1" colspan="1">Activity</th><th rowspan="1" colspan="1">Effectiveness</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">K22</td><td rowspan="1" colspan="1">Targets membrane-bound replication complexes of virus in host cell to inhibit RNA synthesis</td><td rowspan="1" colspan="1">Effective against SARS and MERS, thus could be effective against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B58" ref-type="bibr">58</xref>)</td></tr><tr><td rowspan="1" colspan="1">DRACO</td><td rowspan="1" colspan="1">Targets viral dsRNA to induce apoptosis in cells containing virus</td><td rowspan="1" colspan="1">Effective against a large group of viruses, therefore may have potential to target SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B59" ref-type="bibr">59</xref>)</td></tr><tr><td rowspan="1" colspan="1">Mycophenolic acid</td><td rowspan="1" colspan="1">Targets nucleosides and/or nucleotides to inhibit synthesis of guanine monophosphate</td><td rowspan="1" colspan="1">Effective against a wide range of viruses, however combinatorial therapy with interferon beta1b may be useful for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B56" ref-type="bibr">56</xref>)</td></tr><tr><td rowspan="1" colspan="1">Lopinavir</td><td rowspan="1" colspan="1">Targets 3CLpro enzyme to inhibit its activity</td><td rowspan="1" colspan="1">Effective against a wide range of viruses, including SARS-CoV and MERS-CoV, thus could be a suitable choice for treatment of SARS-CoV-2 infection.</td><td rowspan="1" colspan="1">(<xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1">Remdesivir</td><td rowspan="1" colspan="1">Terminates transcription of viral RNA transcription at premature level</td><td rowspan="1" colspan="1">Effective against a broad spectrum of viruses including MERS-CoV and SARS-CoV. The efficacy is very promising when combined with IFNb, hence could be a suitable therapeutic strategy for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B35" ref-type="bibr">35</xref>)</td></tr><tr><td rowspan="1" colspan="1">Ribavirin</td><td rowspan="1" colspan="1">Targets RdRp (RNA&#x02011;dependent RNA polymerase) enzyme to inhibit synthesis of viral RNA synthesis and capping of mRNA</td><td rowspan="1" colspan="1">Effective against a wide range of viruses, including MERS-CoV and SARS-CoV, but the high doses required may have severe side effects. Could be reevaluated for SARS-CoV-2 and recommended if low doses are found effective.</td><td rowspan="1" colspan="1">(<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1">Bcx4430</td><td rowspan="1" colspan="1">Targets RdRp (RNA&#x02011;dependent RNA polymerase) enzyme to inhibit synthesis of viral RNA synthesis and capping of mRNA</td><td rowspan="1" colspan="1">Broad spectrum and effective against SARS-CoV and MERS-CoV, thus may be effective against SARS-CoV-2, however, evaluation using animal models is required.</td><td rowspan="1" colspan="1">(<xref rid="B61" ref-type="bibr">61</xref>)</td></tr><tr><td rowspan="1" colspan="1">Bananins</td><td rowspan="1" colspan="1">Target helicase to inhibit unwinding and activity of ATPase</td><td rowspan="1" colspan="1">Have effects against broad-spectrum viruses and can be evaluated for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>)</td></tr><tr><td rowspan="1" colspan="1">Aryl diketoacids (Adks)</td><td rowspan="1" colspan="1">Target helicase to inhibit its unwinding</td><td rowspan="1" colspan="1">Effective for a broad range viruses, including SARS/MERS-CoV, and may be a suitable choice for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>)</td></tr><tr><td rowspan="1" colspan="1">Griffithsin</td><td rowspan="1" colspan="1">Targets oligosaccharides on S to block viral binding with host cell</td><td rowspan="1" colspan="1">Has effects against SARS/MERS-CoV and other high pathogenic viruses, thus might be used against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B62" ref-type="bibr">62</xref>)</td></tr><tr><td rowspan="1" colspan="1">Hexamethylene amiloride</td><td rowspan="1" colspan="1">Targets viral envelope to inhibit ion channel activity</td><td rowspan="1" colspan="1">Has effects against different coronaviruses, thus one of the most suitable treatment options for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B63" ref-type="bibr">63</xref>)</td></tr><tr><td rowspan="1" colspan="1">Jl103</td><td rowspan="1" colspan="1">Targets lipid membrane and causes modification of phospholipids</td><td rowspan="1" colspan="1">Has effects against different viruses and may be promising as an anti-SARS-CoV-2 agent.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1">Recombinant interferons</td><td rowspan="1" colspan="1">Induce the innate interferon responses against viral pathogens</td><td rowspan="1" colspan="1">Induce immune responses through recombinant interferons, found effective against a wide range of viruses and can be the most suitable option for SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1">Nitazoxanide</td><td rowspan="1" colspan="1">Induces the innate interferon responses against viral pathogens</td><td rowspan="1" colspan="1">Induces immune responses through recombinant interferons, has been found effective against a wide range of viruses and may be promising to use against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B64" ref-type="bibr">64</xref>)</td></tr><tr><td rowspan="1" colspan="1">Cyclosporine, alisporivir</td><td rowspan="1" colspan="1">Inhibit cyclophilin to affect calcineurin&#x02013;NFAT pathway</td><td rowspan="1" colspan="1">Inhibit broad-spectrum viruses, specifically coronaviruses, and thus could be suitable option to treat SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>)</td></tr><tr><td rowspan="1" colspan="1">Rapamycin</td><td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td><td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B65" ref-type="bibr">65</xref>)</td></tr><tr><td rowspan="1" colspan="1">Imatinib</td><td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td><td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>)</td></tr><tr><td rowspan="1" colspan="1">Dasatinib</td><td rowspan="1" colspan="1">Inhibits kinase signaling associated pathways to block viral entry</td><td rowspan="1" colspan="1">Effective against SARS/MERS-CoV and might possibly be effective against SARS-CoV-2.</td><td rowspan="1" colspan="1">(<xref rid="B1" ref-type="bibr">1</xref>)</td></tr></tbody></table><graphic xlink:href="JCM.00187-20-t0001"/></alternatives></table-wrap><p>Broad-spectrum antivirals, such as dsRNA-activated caspase oligomerizer (DRACO), which selectively induces apoptosis in virus-containing host cells, provide another class to evaluate for effectiveness against SARS-CoV-2 (<xref rid="B50" ref-type="bibr">50</xref>). However, this class does not provide a promising strategy alone, as they cannot block virus entry or disrupt viral nucleic acid. In contrast, thiopurine compounds, naphthalene inhibitors, protease inhibitors, zinc, and mercury conjugates target 3CLpro (3C-like protease) and PLpro (papain-like protease) enzymes in coronaviruses and have been shown to block their pathogenicity (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>). Therefore, combinational therapy of these antiviral agents with DRACO may enhance the overall impact on the recovery of patients. Despite the higher rate of infectiousness, coronaviruses are thought to have the ability to suppress counteracting responses from host innate interferons. This response can be augmented by the utilization of interferon inducers or recombinant interferons (<xref rid="B1" ref-type="bibr">1</xref>). Recombinant interferons such as interferon alpha and interferon beta that have been tested against SARS-CoV (<xref rid="B1" ref-type="bibr">1</xref>) might be utilized either alone or in combination with other potential antiviral drugs, including remdesivir. Both interferon alpha and beta inhibit viral replication (<xref rid="B1" ref-type="bibr">1</xref>). The use of interferon inducers in combination with effective antiviral agents is worth evaluating for possible synergistic effects against SARS-CoV-2. In addition, calcineurin inhibitors such as cyclosporine (<xref rid="B53" ref-type="bibr">53</xref>), in combination with antibiotics and traditional Chinese medicines, could also be evaluated for activity against SARS-CoV-2.</p></sec><sec id="s6"><title>VACCINES</title><p>Effective vaccines are important to prevent and control sporadic viral attacks and emerging virus-mediated epidemics, such as the recent outbreak caused by SARS-CoV-2. Although SARS-CoV was fully controlled during 2003, and MERS-CoV has been prevented from causing high mortality rates, the newly emerged SARS-CoV-2 is spreading efficiently with a significant increase in the number of cases and fatalities during each passing day. Vaccines are required to prevent SARS-CoV-2 from causing COVID-19. Live-attenuated vaccines, such as has been designed for SARS (<xref rid="B1" ref-type="bibr">1</xref>), may be evaluated for SARS-CoV-2 infected patients. In addition rhesus &#x003b8;-defensin 1 and protein cage nanoparticles are innate immunomodulators with high anti-SARS-CoV efficiency (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>). Based on the high similarity and phylogenetic relatedness between SARS-CoV and SARS-CoV-2, protein cage nanoparticles designed for SARS-CoV can be evaluated for SARS-CoV-2. Meanwhile, following similar strategies utilized for SARS-CoV, novel protein cage nanoparticles specified for novel coronavirus can be designed on an emergency basis. Given the urgency in the current scenario of COVID-19 outbreak, vaccination strategies based on viral vectors, recombinant protein, and viral-like particles, which have been developed or are being developed for SARS and/or MERS, could be modified for utilization against SARS-CoV-2 (<xref rid="B56" ref-type="bibr">56</xref>). Despite the current progress, further work is needed to develop safe and effective vaccines, available for individuals at high risk of SARS-CoV-2 endemics, to control the ongoing and risk of future epidemics. Further, an interesting feature of plasma from recovered patients is the presence of active antibodies. The transfer of plasma from people who have recovered from COVID-19 into infected individuals might enhance immunity against SARS-CoV-2. Monoclonal antibodies that could inhibit virus-cell receptor binding and interrupt virus-cell fusion have been developed (<xref rid="B1" ref-type="bibr">1</xref>). Combining two or more monoclonal antibodies may be suitable for the quicker recovery of patients. Lastly, antiviral peptides that target different regions of S, such as HP2P-M2 peptide (effective against viral infections) (<xref rid="B1" ref-type="bibr">1</xref>), should also be considered against COVID-19.</p><p>Although some strategies against SARS-CoV are being developed, including receptor-binding domain (RBD)-based vaccines, they require further evaluation (<xref rid="B2" ref-type="bibr">2</xref>). Given the importance of the current outbreak in Wuhan, further studies are needed to deepen understanding of replication, pathogenesis, and biological properties using reverse genetics and related molecular techniques. These investigations will help the control and prevention of SARS-CoV-2-mediated pneumonia disease and novel emerging diseases in the future.</p></sec><sec id="s7"><title>FUTURE PERSPECTIVES</title><p>SARS-CoV and MERS-CoV were reported to originate from recombination within bat viruses before their introduction into Guangdong province through civets and the Middle East through camels, respectively. Some of the SARS-CoV strains became epidemic after several independent spillovers to humans during the outbreak of 2002 in Guangdong, China (<xref rid="B3" ref-type="bibr">3</xref>). Similarly, MERS-CoV became epidemic after a series of human infections in 2012 in Middle Eastern countries (<xref rid="B33" ref-type="bibr">33</xref>). Both viruses transferred to several countries beyond the countries of origin. However, unlike the continuous propagation of the MERS-CoV epidemic, the SARS-CoV outbreak was successfully controlled in 2003. Based on the origin of other coronaviruses, SARS-CoV-2 is likely to have originated in bats and have been introduced to Wuhan, China through an unknown intermediate. Until now, no effective clinical treatments or prevention strategies are available to be used against human coronaviruses.</p><p>Testing drugs against coronaviruses requires suitable animal models prior to their use in humans. The currently established models are not very promising for the studies of pathogenesis and treatment of highly pathogenic coronaviruses. For instance, nonhuman primates were unable to reproduce the characteristics of the severe human disease and mortality was not observed (<xref rid="B57" ref-type="bibr">57</xref>). However, some small animals have developed clinical symptoms of disease (<xref rid="B57" ref-type="bibr">57</xref>), such as transgenic mice expressing human ACE2, and mouse-adapted SARS-CoV strains are one of the most suitable models (<xref rid="B1" ref-type="bibr">1</xref>). Additionally, transgenic mice expressing human DPP4 are a suitable small animal model for MERS (<xref rid="B1" ref-type="bibr">1</xref>). Like the animal models for SARS-CoV, transgenic animal models may also be standardized for SARS-CoV-2. The development of clinical drugs for coronaviruses is challenging because of the repeated emergence of novel coronaviruses with diverse features, thus requiring specific drugs for each newly emerged virus. Moreover, only a limited number of animal models are available and most of them can only be used in highly demanding biosafety level 3 labs (<xref rid="B1" ref-type="bibr">1</xref>). From the perspective of the current outbreak, designing effective therapeutics for SARS-CoV-2 is yet another challenge for scientists. Although a large number of antiviral treatment options for SARS and MERS have been reported with potent <italic>in vitro</italic> activities, a very limited number of these may have potential in the clinical setting.</p><p>Moving forward there are treatment options available that could be utilized clinically during the ongoing SARS-CoV-2 epidemic. Some of the broad-spectrum antiviral drugs may be effective for SARS-CoV-2, and there is opportunity to test them in the current scenario of pneumonia in Wuhan, China. Broad-range combinational therapies, including lopinavir and interferon antiviral peptides, can also be evaluated and examined, as these agents have shown significant effects against MERS in nonhuman primates (<xref rid="B1" ref-type="bibr">1</xref>). The design and development of novel broad-spectrum antiviral drugs that can potentially target all coronaviruses may prove to be the best treatment option against reemerging and circulating coronaviruses.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We acknowledge a postdoctoral grant from the Second Affiliated Hospital of Zhengzhou University (for S.K.) and operating grant support from the National Natural Science Foundation of China (grant numbers 81870942, 81471174 and 81520108011), National Key Research and Development Program of China (grant number 2018YFC1312200), and Innovation Scientists and Technicians Troop Constructions Projects of Henan Province of China (for M.X.).</p><p>We declare no conflicts of interest.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zumla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>JFW</given-names></name>, <name name-style="western"><surname>Azhar</surname><given-names>EI</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>DSC</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>KY</given-names></name></person-group>
<year>2016</year>
<article-title>Coronaviruses&#x02014;drug discovery and therapeutic options</article-title>. <source>Nat Rev Drug Discov</source>
<volume>15</volume>:<fpage>327</fpage>&#x02013;<lpage>347</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd.2015.37</pub-id>.<pub-id pub-id-type="pmid">26868298</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>ZL</given-names></name></person-group>
<year>2019</year>
<article-title>Origin and evolution of pathogenic coronaviruses</article-title>. <source>Nat Rev Microbiol</source>
<volume>17</volume>:<fpage>181</fpage>&#x02013;<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-018-0118-9</pub-id>.<pub-id pub-id-type="pmid">30531947</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>ZH</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>JP</given-names></name></person-group>
<year>2003</year>
<article-title>Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People&#x02019;s Republic of China, in February, 2003</article-title>. <source>Lancet</source>
<volume>362</volume>:<fpage>1353</fpage>&#x02013;<lpage>1358</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(03)14630-2</pub-id>.<pub-id pub-id-type="pmid">14585636</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bawazir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Al-Mazroo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jradi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Badri</surname><given-names>M</given-names></name></person-group>
<year>2018</year>
<article-title>MERS-CoV infection: mind the public knowledge gap</article-title>. <source>J Infect Public Health</source>
<volume>11</volume>:<fpage>89</fpage>&#x02013;<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jiph.2017.05.003</pub-id>.<pub-id pub-id-type="pmid">28647126</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaki</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Van Boheemen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bestebroer</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Osterhaus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fouchier</surname><given-names>R</given-names></name></person-group>
<year>2012</year>
<article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title>. <source>N Engl J Med</source>
<volume>367</volume>:<fpage>1814</fpage>&#x02013;<lpage>1820</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1211721</pub-id>.<pub-id pub-id-type="pmid">23075143</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nabi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Siddique</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bashir</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shereen</surname><given-names>MA</given-names></name></person-group>
<year>2020</year>
<article-title>Novel coronavirus: how the things are in Wuhan</article-title>. <source>Clin Microbiol Infect</source> doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2020.02.005</pub-id>.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>D</given-names></name></person-group>
<year>2020</year>
<article-title>Emerging coronaviruses: genome structure, replication, and pathogenesis</article-title>. <source>J Med Virol</source>
<volume>92</volume>:<fpage>418</fpage>&#x02013;<lpage>423</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jmv.25681</pub-id>.<pub-id pub-id-type="pmid">31967327</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hui</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>I Azhar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Madani</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Ntoumi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kock</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dar</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ippolito</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mchugh</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Memish</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zumla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>E</given-names></name></person-group>
<year>2020</year>
<article-title>The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health&#x02014;the latest 2019 novel coronavirus outbreak in Wuhan, China</article-title>. <source>Int J Infect Dis</source>
<volume>91</volume>:<fpage>264</fpage>&#x02013;<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijid.2020.01.009</pub-id>.<pub-id pub-id-type="pmid">31953166</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zai</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group>
<year>2020</year>
<article-title>Cross-species transmission of the newly identified coronavirus 2019-nCoV</article-title>. <source>J Med Virol</source>
<volume>92</volume>:<fpage>433</fpage>&#x02013;<lpage>440</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jmv.25682</pub-id>.<pub-id pub-id-type="pmid">31967321</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Travanty</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Oko</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Edeen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Berglund</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>RJ</given-names></name></person-group>
<year>2013</year>
<article-title>Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus</article-title>. <source>Am J Respir Cell Mol Biol</source>
<volume>48</volume>:<fpage>742</fpage>&#x02013;<lpage>748</lpage>. doi:<pub-id pub-id-type="doi">10.1165/rcmb.2012-0339OC</pub-id>.<pub-id pub-id-type="pmid">23418343</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raj</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Mou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Smits</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Dekkers</surname><given-names>DHW</given-names></name>, <name name-style="western"><surname>M&#x000fc;ller</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Dijkman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Muth</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Demmers</surname><given-names>JAA</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fouchier</surname><given-names>RAM</given-names></name>, <name name-style="western"><surname>Thiel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rottier</surname><given-names>PJM</given-names></name>, <name name-style="western"><surname>Osterhaus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bosch</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Haagmans</surname><given-names>BL</given-names></name></person-group>
<year>2013</year>
<article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title>. <source>Nature</source>
<volume>495</volume>:<fpage>251</fpage>&#x02013;<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12005</pub-id>.<pub-id pub-id-type="pmid">23486063</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X-L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X-G</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Si</surname><given-names>H-R</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C-L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H-D</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>R-D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M-Q</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X-R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X-S</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q-J</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L-L</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>F-X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y-Y</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>G-F</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Z-L</given-names></name></person-group>
<year>2020</year>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>. <source>Nature</source> doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id>.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>He</surname><given-names>YQ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Zhuang</surname><given-names>ZX</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Butt</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shortridge</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Peiris</surname><given-names>JSM</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></name></person-group>
<year>2003</year>
<article-title>Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China</article-title>. <source>Science</source>
<volume>302</volume>:<fpage>276</fpage>&#x02013;<lpage>278</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1087139</pub-id>.<pub-id pub-id-type="pmid">12958366</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alagaili</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Briese</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mishra</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kapoor</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sameroff</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Burbelo</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Munster</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Hensley</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Zalmout</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Kapoor</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Karesh</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Daszak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mohammed</surname><given-names>OB</given-names></name>, <name name-style="western"><surname>Lipkin</surname><given-names>WI</given-names></name></person-group>
<year>2014</year>
<article-title>Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia</article-title>. <source>mBio</source>
<volume>5</volume>:<comment>e00884-14-e00814</comment>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00884-14</pub-id>.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarris</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kavanagh</surname><given-names>DJ</given-names></name></person-group>
<year>2009</year>
<article-title>Kava and St. John&#x02019;s Wort: current evidence for use in mood and anxiety disorders</article-title>. <source>J Altern Complement Med</source>
<volume>15</volume>:<fpage>827</fpage>&#x02013;<lpage>836</lpage>. doi:<pub-id pub-id-type="doi">10.1089/acm.2009.0066</pub-id>.<pub-id pub-id-type="pmid">19614563</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ithete</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Stoffberg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Corman</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Cottontail</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Schoeman</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Drexler</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Preiser</surname><given-names>W</given-names></name></person-group>
<year>2013</year>
<article-title>Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa</article-title>. <source>Emerg Infect Dis</source>
<volume>19</volume>:<fpage>1697</fpage>&#x02013;<lpage>1699</lpage>. doi:<pub-id pub-id-type="doi">10.3201/eid1910.130946</pub-id>.<pub-id pub-id-type="pmid">24050621</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>X</given-names></name></person-group>
<year>2020</year>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>
<volume>395</volume>:<fpage>497</fpage>&#x02013;<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>.<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>ACK</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name></person-group>
<year>2016</year>
<article-title>Epidemiology, genetic recombination, and pathogenesis of coronaviruses</article-title>. <source>Trends Microbiol</source>
<volume>24</volume>:<fpage>490</fpage>&#x02013;<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tim.2016.03.003</pub-id>.<pub-id pub-id-type="pmid">27012512</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forni</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cagliani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Clerici</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sironi</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Molecular evolution of human coronavirus genomes</article-title>. <source>Trends Microbiol</source>
<volume>25</volume>:<fpage>35</fpage>&#x02013;<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tim.2016.09.001</pub-id>.<pub-id pub-id-type="pmid">27743750</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>ZB</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>XZ</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XN</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>BY</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SJ</given-names></name></person-group>
<year>2004</year>
<article-title>Analysis on the risk factors of severe acute respiratory syndromes coronavirus infection in workers from animal markets. (In Chinese.)</article-title>
<source>Zhonghua Liu Xing Bing Xue Za Zhi</source>
<volume>25</volume>:<fpage>503</fpage>&#x02013;<lpage>505</lpage>.<pub-id pub-id-type="pmid">15231128</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>H-D</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>C-C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>G-W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S-Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>L-C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q-X</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y-W</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H-Q</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>H-J</given-names></name>, <name name-style="western"><surname>Chern</surname><given-names>S-WW</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>C-M</given-names></name>, <name name-style="western"><surname>Xuan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S-J</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>H-M</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>D-H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y-F</given-names></name>, <name name-style="western"><surname>He</surname><given-names>J-F</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>P-Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L-H</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>Y-Q</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>W-J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y-D</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R-H</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X-W</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>H-Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J-D</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>L-Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Di</surname><given-names>B</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L-J</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J-Y</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bernini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>X-J</given-names></name>, <name name-style="western"><surname>Spiga</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>Z-M</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>H-Y</given-names></name>, <name name-style="western"><surname>He</surname><given-names>W-Z</given-names></name>, <name name-style="western"><surname>Manuguerra</surname><given-names>J-C</given-names></name>, <name name-style="western"><surname>Fontanet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Danchin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Niccolai</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y-X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>C-I</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>G-P</given-names></name></person-group>
<year>2005</year>
<article-title>Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>:<fpage>2430</fpage>&#x02013;<lpage>2435</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0409608102</pub-id>.<pub-id pub-id-type="pmid">15695582</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>SKP</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PCY</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>KSM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tsoi</surname><given-names>H-W</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>BHL</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>SSY</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>S-Y</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K-H</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>K-Y</given-names></name></person-group>
<year>2005</year>
<article-title>Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>:<fpage>14040</fpage>&#x02013;<lpage>14045</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0506735102</pub-id>.<pub-id pub-id-type="pmid">16169905</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>L-P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X-L</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>X-Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>J-Z</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X-R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y-Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>D-S</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X-S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M-N</given-names></name>, <name name-style="western"><surname>Daszak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L-F</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Z-L</given-names></name></person-group>
<year>2017</year>
<article-title>Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus</article-title>. <source>PLoS Pathog</source>
<volume>13</volume>:<elocation-id>e1006698</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1006698</pub-id>.<pub-id pub-id-type="pmid">29190287</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Crameri</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McEachern</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Field</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Daszak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L-F</given-names></name></person-group>
<year>2005</year>
<article-title>Bats are natural reservoirs of SARS-like coronaviruses</article-title>. <source>Science</source>
<volume>310</volume>:<fpage>676</fpage>&#x02013;<lpage>679</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1118391</pub-id>.<pub-id pub-id-type="pmid">16195424</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paden</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Yusof</surname><given-names>MFBM</given-names></name>, <name name-style="western"><surname>Al Hammadi</surname><given-names>ZM</given-names></name>, <name name-style="western"><surname>Queen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Eltahir</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Elsayed</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Marzoug</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Bensalah</surname><given-names>OKA</given-names></name>, <name name-style="western"><surname>Khalafalla</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Al Mulla</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Khudhair</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Elkheir</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Issa</surname><given-names>ZB</given-names></name>, <name name-style="western"><surname>Pradeep</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Elsaleh</surname><given-names>FN</given-names></name>, <name name-style="western"><surname>Imambaccus</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sasse</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pham</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Al Hosani</surname><given-names>FI</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al Muhairi</surname><given-names>SSM</given-names></name></person-group>
<year>2018</year>
<article-title>Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE</article-title>. <source>Zoonoses Public Health</source>
<volume>65</volume>:<fpage>322</fpage>&#x02013;<lpage>333</lpage>. doi:<pub-id pub-id-type="doi">10.1111/zph.12435</pub-id>.<pub-id pub-id-type="pmid">29239118</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>DKW</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>KPY</given-names></name>, <name name-style="western"><surname>Perera</surname><given-names>RAPM</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Niemeyer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Channappanavar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dudas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Oladipo</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Traor&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fassi-Fihri</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Demissi&#x000e9;</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Muth</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>MCW</given-names></name>, <name name-style="western"><surname>Nicholls</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Meyerholz</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Kuranga</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Mamo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>So</surname><given-names>RTY</given-names></name>, <name name-style="western"><surname>Hemida</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Webby</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Roger</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></name>, <name name-style="western"><surname>Perlman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Peiris</surname><given-names>M</given-names></name></person-group>
<year>2018</year>
<article-title>MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>115</volume>:<fpage>3144</fpage>&#x02013;<lpage>3149</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1718769115</pub-id>.<pub-id pub-id-type="pmid">29507189</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>SKP</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>KSM</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>AKL</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>CSF</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K-H</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PCY</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>K-Y</given-names></name></person-group>
<year>2013</year>
<article-title>Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus</article-title>. <source>J Virol</source>
<volume>87</volume>:<fpage>8638</fpage>&#x02013;<lpage>8650</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01055-13</pub-id>.<pub-id pub-id-type="pmid">23720729</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>SKP</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Luk</surname><given-names>HKH</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>KSM</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>PS-H</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>RYY</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>ACP</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>J-P</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>JFW</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>TCK</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>RKH</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>K-Y</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PCY</given-names></name></person-group>
<year>2018</year>
<article-title>Receptor usage of a novel bat lineage c betacoronavirus reveals evolution of Middle East respiratory syndrome-related coronavirus spike proteins for human dipeptidyl peptidase 4 binding</article-title>. <source>J Infect Dis</source>
<volume>218</volume>:<fpage>197</fpage>&#x02013;<lpage>207</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiy018</pub-id>.<pub-id pub-id-type="pmid">29346682</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W</given-names></name></person-group>
<year>2020</year>
<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title>. <source>Lancet</source>
<volume>395</volume>:<fpage>565</fpage>&#x02013;<lpage>574</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id>.<pub-id pub-id-type="pmid">32007145</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Provincial</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Health</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hospital</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Hospital</surname><given-names>B</given-names></name></person-group>
<year>2020</year>
<article-title>Full genome NJ tree all CoV families Maximum likelihood tree of all outbreak sequences with orf1a region 2020&#x02013;01-23 All outbreak sequences so far are very closely</article-title>.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Quan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W</given-names></name></person-group>
<year>2020</year>
<article-title>Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China</article-title>. <source>Cell Host Microbe</source> doi:<pub-id pub-id-type="doi">10.1016/j.chom.2020.02.001</pub-id>.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hawkey</surname><given-names>PM</given-names></name></person-group>
<year>2003</year>
<article-title>Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China</article-title>. <source>J Med Microbiol</source>
<volume>52</volume>:<fpage>715</fpage>&#x02013;<lpage>720</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.05320-0</pub-id>.<pub-id pub-id-type="pmid">12867568</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Groot</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Baric</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Enjuanes</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fouchier</surname><given-names>RAM</given-names></name>, <name name-style="western"><surname>Galiano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gorbalenya</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Memish</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Perlman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></name>, <name name-style="western"><surname>Snijder</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PCY</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Zambon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ziebuhr</surname><given-names>J</given-names></name></person-group>
<year>2013</year>
<article-title>Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group</article-title>. <source>J Virol</source>
<volume>87</volume>:<fpage>7790</fpage>&#x02013;<lpage>7792</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01244-13</pub-id>.<pub-id pub-id-type="pmid">23678167</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hijawi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Abdallat</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sayaydeh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alqasrawi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haddadin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jaarour</surname><given-names>N</given-names></name>, <name name-style="western"><surname>El Sheikh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Alsanouri</surname><given-names>T</given-names></name></person-group>
<year>2013</year>
<article-title>Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation</article-title>. <source>East Mediterr Health J</source>
<volume>19</volume>:<fpage>S12</fpage>&#x02013;<lpage>S18</lpage>. doi:<pub-id pub-id-type="doi">10.26719/2013.19.supp1.S12</pub-id>.<pub-id pub-id-type="pmid">23888790</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheahan</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Sims</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Leist</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Sch&#x000e4;fer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Won</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Hogg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Babusis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Spahn</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sellers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Cihlar</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Denison</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Baric</surname><given-names>RS</given-names></name></person-group>
<year>2020</year>
<article-title>Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV</article-title>. <source>Nat Commun</source>
<volume>11</volume>. doi:<pub-id pub-id-type="doi">10.1038/s41467-019-13940-6</pub-id>.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Killerby</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Biggs</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Midgley</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>JT</given-names></name></person-group>
<year>2020</year>
<article-title>Middle East Respiratory Syndrome coronavirus transmission</article-title>
<volume>26</volume>:<fpage>191</fpage>&#x02013;<lpage>198</lpage>.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W</given-names></name></person-group>, <collab>for the China Novel Coronavirus Investigating and Research Team</collab>. <year>2020</year>
<article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title>. <source>N Engl J Med</source>
<volume>382</volume>:<fpage>727</fpage>&#x02013;<lpage>733</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id>.<pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="web"><collab>World Health Organization</collab>. <year>2020</year>
<article-title>Coronavirus disease 2019 (COVID-19), situation report &#x02013; 35</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200224-sitrep-35-covid-19.pdf?sfvrsn=1ac4218d_2">https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200224-sitrep-35-covid-19.pdf?sfvrsn=1ac4218d_2</ext-link>.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>KSM</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>EHY</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>TTY</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>JTK</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Cowling</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z</given-names></name></person-group>
<year>2020</year>
<article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</article-title>. <source>N Engl J Med</source> doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schunk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sothmann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bretzel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Froeschl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wallrauch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Thiel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Janke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Guggemos</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Seilmaier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vollmar</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zwirglmaier</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zange</surname><given-names>S</given-names></name>, <name name-style="western"><surname>W&#x000f6;lfel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoelscher</surname><given-names>M</given-names></name></person-group>
<year>2020</year>
<article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</article-title>. <source>N Engl J Med</source>
<volume>382</volume>:<fpage>970</fpage>&#x02013;<lpage>971</lpage>. <comment>2019&#x02013;2020</comment>. doi:<pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id>.<pub-id pub-id-type="pmid">32003551</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JFW</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>To</surname><given-names>KKW</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>CCY</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>RWS</given-names></name>, <name name-style="western"><surname>Tsoi</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>SKF</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>VKM</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Ip</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>VCC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>CKM</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>KY</given-names></name></person-group>
<year>2020</year>
<article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</article-title>. <source>Lancet</source>
<volume>395</volume>:<fpage>514</fpage>&#x02013;<lpage>523</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30154-9</pub-id>.<pub-id pub-id-type="pmid">31986261</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2020</year> Guidelines for samples for COVID-19, Feb 11, 2020. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html">https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html</ext-link>.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <year>2012</year>
<article-title>Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain novel coronavirus 2012, interim recommendations</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/disease/coronavirus_infections/Biosafety_InterimRecommendations_NovelCoronavirus2012_31Oct12.pdf?ua=1">https://www.who.int/csr/disease/coronavirus_infections/Biosafety_InterimRecommendations_NovelCoronavirus2012_31Oct12.pdf?ua=1</ext-link>.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>G</given-names></name></person-group>
<year>2020</year>
<article-title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</article-title>. <source>Cell Res</source>
<volume>30</volume>:<fpage>269</fpage>&#x02013;<lpage>271</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41422-020-0282-0</pub-id>.<pub-id pub-id-type="pmid">32020029</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holshue</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>DeBolt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lindquist</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lofy</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Wiesman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bruce</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Spitters</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ericson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wilkerson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tural</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lindstrom</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pallansch</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Weldon</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Biggs</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Uyeki</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Pillai</surname><given-names>SK</given-names></name></person-group>, <collab>Washington State 2019-nCoV Case Investigation Team</collab>. <year>2020</year>
<article-title>First case of 2019 novel coronavirus in the United States</article-title>. <source>N Engl J Med</source>
<volume>382</volume>:<fpage>929</fpage>&#x02013;<lpage>936</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id>.<pub-id pub-id-type="pmid">32004427</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JFW</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>SKP</given-names></name>, <name name-style="western"><surname>To</surname><given-names>KKW</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>VCC</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PCY</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>K-Y</given-names></name></person-group>
<year>2015</year>
<article-title>Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease</article-title>. <source>Clin Microbiol Rev</source>
<volume>28</volume>:<fpage>465</fpage>&#x02013;<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.00102-14</pub-id>.<pub-id pub-id-type="pmid">25810418</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Millet</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Whittaker</surname><given-names>GR</given-names></name></person-group>
<year>2014</year>
<article-title>Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>111</volume>:<fpage>15214</fpage>&#x02013;<lpage>15219</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1407087111</pub-id>.<pub-id pub-id-type="pmid">25288733</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirato</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawase</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Matsuyama</surname><given-names>S</given-names></name></person-group>
<year>2013</year>
<article-title>Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2</article-title>. <source>J Virol</source>
<volume>87</volume>:<fpage>12552</fpage>&#x02013;<lpage>12561</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01890-13</pub-id>.<pub-id pub-id-type="pmid">24027332</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dijkman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bergstr&#x000f6;m</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kann</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Adamiak</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hannoun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kindler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>J&#x000f3;nsd&#x000f3;ttir</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Muth</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kint</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Forlenza</surname><given-names>M</given-names></name>, <name name-style="western"><surname>M&#x000fc;ller</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thiel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Trybala</surname><given-names>E</given-names></name></person-group>
<year>2014</year>
<article-title>Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus</article-title>. <source>PLoS Pathog</source>
<volume>10</volume>:<elocation-id>e1004166</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004166</pub-id>.<pub-id pub-id-type="pmid">24874215</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rider</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Zook</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Boettcher</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Wick</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Pancoast</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Zusman</surname><given-names>BD</given-names></name></person-group>
<year>2011</year>
<article-title>Broad-spectrum antiviral therapeutics</article-title>. <source>PLoS One</source>
<volume>6</volume>:<elocation-id>e22572</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0022572</pub-id>.<pub-id pub-id-type="pmid">21818340</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#x000e1;ez-Santos</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>John</surname><given-names>SES</given-names></name>, <name name-style="western"><surname>Mesecar</surname><given-names>AD</given-names></name></person-group>
<year>2015</year>
<article-title>The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds</article-title>. <source>Antiviral Res</source>
<volume>115</volume>:<fpage>21</fpage>&#x02013;<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.antiviral.2014.12.015</pub-id>.<pub-id pub-id-type="pmid">25554382</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adedeji</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Sarafianos</surname><given-names>SG</given-names></name></person-group>
<year>2014</year>
<article-title>Antiviral drugs specific for coronaviruses in preclinical development</article-title>. <source>Curr Opin Virol</source>
<volume>8</volume>:<fpage>45</fpage>&#x02013;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coviro.2014.06.002</pub-id>.<pub-id pub-id-type="pmid">24997250</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Tawfiq</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Hinedi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ghandour</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Khairalla</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Musleh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ujayli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Memish</surname><given-names>ZA</given-names></name></person-group>
<year>2014</year>
<article-title>Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients</article-title>. <source>Clin Infect Dis</source>
<volume>59</volume>:<fpage>160</fpage>&#x02013;<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciu226</pub-id>.<pub-id pub-id-type="pmid">24723278</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlford-Lenane</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Meyerholz</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Perlman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Selsted</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>McCray</surname><given-names>PB</given-names></name></person-group>
<year>2009</year>
<article-title>Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease</article-title>. <source>J Virol</source>
<volume>83</volume>:<fpage>11385</fpage>&#x02013;<lpage>11390</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01363-09</pub-id>.<pub-id pub-id-type="pmid">19710146</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiley</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Richert</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Swain</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Barnard</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Randall</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Jutila</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Broomell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>A</given-names></name></person-group>
<year>2009</year>
<article-title>Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses</article-title>. <source>PLoS One</source>
<volume>4</volume>:<elocation-id>e7142</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0007142</pub-id>.<pub-id pub-id-type="pmid">19774076</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mubarak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alturaiki</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Hemida</surname><given-names>MG</given-names></name></person-group>
<year>2019</year>
<article-title>Middle East respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development</article-title>. <source>J Immunol Res</source>
<volume>2019</volume>:<fpage>6491738</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2019/6491738</pub-id>.<pub-id pub-id-type="pmid">31089478</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Subbarao</surname><given-names>K</given-names></name></person-group>
<year>2015</year>
<article-title>Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus</article-title>. <source>Virology</source>
<volume>479&#x02013;480</volume>:<fpage>247</fpage>&#x02013;<lpage>258</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2015.02.030</pub-id>.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Momattin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Al-Ali</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Al-Tawfiq</surname><given-names>JA</given-names></name></person-group>
<year>2019</year>
<article-title>A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV)</article-title>. <source>Travel Med Infect Dis</source>
<volume>30</volume>:<fpage>9</fpage>&#x02013;<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tmaid.2019.06.012</pub-id>.<pub-id pub-id-type="pmid">31252170</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mielech</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Kilianski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baez-Santos</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Mesecar</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>SC</given-names></name></person-group>
<year>2014</year>
<article-title>MERS-CoV papain-like protease has deISGylating and deubiquitinating activities</article-title>. <source>Virology</source>
<volume>450</volume>:<fpage>64</fpage>&#x02013;<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2013.11.040</pub-id>.<pub-id pub-id-type="pmid">24503068</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Totura</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Bavari</surname><given-names>S</given-names></name></person-group>
<year>2019</year>
<article-title>Broad-spectrum coronavirus antiviral drug discovery</article-title>. <source>Expert Opin Drug Discov</source>
<volume>14</volume>:<fpage>397</fpage>&#x02013;<lpage>412</lpage>. doi:<pub-id pub-id-type="doi">10.1080/17460441.2019.1581171</pub-id>.<pub-id pub-id-type="pmid">30849247</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pruijssers</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Denison</surname><given-names>MR</given-names></name></person-group>
<year>2019</year>
<article-title>Nucleoside analogues for the treatment of coronavirus infections</article-title>. <source>Curr Opin Virol</source>
<volume>35</volume>:<fpage>57</fpage>&#x02013;<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coviro.2019.04.002</pub-id>.<pub-id pub-id-type="pmid">31125806</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kouokam</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Lasnik</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Foreman</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Cambon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Brock</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Montefiori</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Vojdani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>McCormick</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>O'Keefe</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>KE</given-names></name></person-group>
<year>2014</year>
<article-title>Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>58</volume>:<fpage>120</fpage>&#x02013;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01407-13</pub-id>.<pub-id pub-id-type="pmid">24145548</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pervushin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parthasarathy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vararattanavech</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Soong</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>DX</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>Structure and inhibition of the SARS coronavirus envelope protein ion channel</article-title>. <source>PLoS Pathog</source>
<volume>5</volume>:<elocation-id>e1000511</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1000511</pub-id>.<pub-id pub-id-type="pmid">19593379</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shakya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>SK</given-names></name></person-group>
<year>2018</year>
<article-title>Update on nitazoxanide: a multifunctional chemotherapeutic agent</article-title>. <source>Curr Drug Discov Technol</source>
<volume>15</volume>:<fpage>201</fpage>&#x02013;<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1570163814666170727130003</pub-id>.<pub-id pub-id-type="pmid">28748751</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma-Lauer</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Male&#x00161;evi&#x00107;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>von Brunn</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>von Brunn</surname><given-names>A</given-names></name></person-group>
<year>2020</year>
<article-title>Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication</article-title>. <source>Antiviral Res</source>
<volume>173</volume>:<fpage>104620</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104620</pub-id>.<pub-id pub-id-type="pmid">31634494</pub-id></mixed-citation></ref></ref-list></back></article>